Latest filings (excl ownership)
424B5
Prospectus supplement for primary offering
2 May 24
424B5
Prospectus supplement for primary offering
2 May 24
424B5
Prospectus supplement for primary offering
2 May 24
8-K
Regulation FD Disclosure
30 Apr 24
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
8-K
Regulation FD Disclosure
18 Apr 24
S-1/A
IPO registration (amended)
17 Apr 24
424B5
Prospectus supplement for primary offering
15 Apr 24
424B5
Prospectus supplement for primary offering
12 Apr 24
424B5
Prospectus supplement for primary offering
11 Apr 24
424B5
Prospectus supplement for primary offering
9 Apr 24
S-1/A
IPO registration (amended)
5 Apr 24
8-K
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
5 Apr 24
8-K
Material Modifications to Rights of Security Holders
4 Apr 24
8-K
Regulation FD Disclosure
1 Apr 24
8-K
Regulation FD Disclosure
26 Mar 24
S-8
Registration of securities for employees
25 Mar 24
8-K
Entry into a Material Definitive Agreement
19 Mar 24
424B5
Prospectus supplement for primary offering
19 Mar 24
8-K
Entry into a Material Definitive Agreement
15 Mar 24
8-K
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
8 Mar 24
10-K
2023 FY
Annual report
8 Mar 24
DEF 14A
Definitive proxy
7 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
PRER14A
Preliminary revised proxy
23 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
D
$1.40 mm in debt, sold $400.00 k, 1 investor
2 Feb 24
8-K
Termination of a Material Definitive Agreement
1 Feb 24
PRE 14A
Preliminary proxy
26 Jan 24
8-K
Entry into a Material Definitive Agreement
25 Jan 24
8-K
Entry into a Material Definitive Agreement
19 Jan 24
S-1/A
IPO registration (amended)
15 Dec 23
8-K
Departure of Directors or Certain Officers
11 Dec 23
8-K
Regulation FD Disclosure
6 Dec 23
S-1/A
IPO registration (amended)
6 Dec 23
8-K
Regulation FD Disclosure
5 Dec 23
S-1/A
IPO registration (amended)
4 Dec 23
EFFECT
Notice of effectiveness
30 Nov 23
CORRESP
Correspondence with SEC
27 Nov 23
Latest ownership filings
SC 13G/A
3i, LP
12 Feb 24
3
Laura Benjamin
28 Aug 23
3
Joseph Walter Vazzano
2 Aug 23
SC 13G
INTRACOASTAL CAPITAL, LLC
14 Jul 23
SC 13G
INTRACOASTAL CAPITAL, LLC
28 Apr 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
10 Mar 23
SC 13G
3i, LP
2 Mar 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
26 Jan 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
25 Jan 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
24 Jan 23
3
Gerald W. McLaughlin
3 Oct 22
4
Jens Erik Knudsen
14 Jul 22
3
David Roth
11 Jul 22
3
Joan Yvonne Brown
6 Jul 22
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
20 Jan 22
SC 13G
Forsakringsaktiebolaget Avanza Pension
27 Dec 21
SC 13G
Sass & Larsen ApS
22 Dec 21
3
Thomas Jensen
22 Dec 21
3
& Larsen ApS Sass
22 Dec 21
3
Steen Knudsen
22 Dec 21
3
Steve Carchedi
22 Dec 21
3
Soren Gade Jensen
22 Dec 21
3
Marie Foegh
22 Dec 21
3
Jens Erik Knudsen
22 Dec 21
3
James G. Cullem
22 Dec 21
3
Gail J Maderis
22 Dec 21
3
Duncan Moore
22 Dec 21